


Vaccinex Revenue
Biotechnology Research • Brighton, New York, United States • 21-50 Employees
Vaccinex revenue & valuation
| Annual revenue | $601,000 |
| Revenue per employee | $21,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Key Contacts at Vaccinex
Leslie Balch
Director Of Antibody Discovery
Loretta Mueller
Director, Laboratory Operations
Maria Mastri Scrivens
Director Of Technology Development
Company overview
| Headquarters | 1895 Mt Hope Ave, Rochester, New York 14620, US |
| Phone number | +15852712700 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Employees | 21-50 |
| Socials |
Vaccinex Email Formats
Vaccinex uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@vaccinex.com), used 75% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@vaccinex.com | 75% |
{f2}{last name} | {f2}doe@vaccinex.com | 10% |
{last name}{last name} | doedoe@vaccinex.com | 10% |
{first name}{last name} | johndoe@vaccinex.com | 5% |
About Vaccinex
Vaccinex (NASDAQ: VCNX) is a clinical stage biotechnology company pioneering a differentiated approach to treating cancer and progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The Company’s lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infiltration into tumors and triggers damaging inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer’s Disease, with ongoing exploration of potential Phase 3 development in Huntington’s disease. The Company has also developed a proprietary drug discovery platform, ActivMAb®, that it is leveraging thru strategic collaborations, particularly by exploiting its unique capability to select high value antibodies against important multi-pass membrane receptors.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Vaccinex has 10 employees across 5 departments.
Departments
Number of employees
Funding Data
Vaccinex has never raised funding before.
Vaccinex Tech Stack
Discover the technologies and tools that power Vaccinex's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Font scripts
JavaScript libraries
Tag managers
Hosting
Reverse proxies
Form builders
Programming languages
JavaScript frameworks
Blogs
Analytics
Frequently asked questions
4.8
40,000 users



